Skip to main content
editor@ajptr.com
9409046853
e-ISSN: 2249-3387
American Journal of PharmTech Research

American Journal of PharmTech Research

LoginTrack Your Paper
Published

Formulation and Evaluation of Oral Medicated Jelly Containing Diclofenac Sodium and Dicyclomine HCl

,

Published in October 2026 Issue 5 (Vol. 16, Issue 5, 2026)

Formulation and Evaluation of Oral Medicated Jelly Containing Diclofenac Sodium and Dicyclomine HCl - Issue cover

Keywords

Oral medicated jellyDissolution efficiencyMean dissolution time.

Abstract

Oral medicated jellies are a promising alternative dosage forms for patients who experience difficulty in swallowing the conventional dosage forms like tablets and capsules. The present study aimed to formulate and evaluate oral medicated jellies containing Diclofenac sodium, a non-steroidal anti-inflammatory drug, and Dicyclomine HCl, an antispasmodic agent, using different concentrations and combinations of gelatin and xanthan gum. Solid dispersion of with beta- cyclodextrin was prepared by the kneading method. Nine formulations of oral jellies (F1–F9) were prepared by the heating and congealing method using gelatin, xanthan gum, and their combinations. The formulations were evaluated for physical appearance, compatibility using FTIR, weight variation, pH, syneresis, drug content, and in-vitro drug release. The dissolution studies were performed using USP apparatus II in phosphate buffer pH 6.8 for 120 min. Dissolution efficiency (%) and mean dissolution time (MDT) were determined. The results of FTIR studies indicated compatibility between the drugs and excipients. The formulations exhibited acceptable physicochemical properties. Formulation F4 showed the highest drug release of 91.11 ± 0.22% and 94.81 ± 0.21% at 30 min for Diclofenac sodium and Dicyclomine HCl, respectively. The Dissolution efficiency of formulation F4 was 57.31% and 68.75% at 30 min, while the mean dissolution time was 16.56 min and 15.08 min, respectively. Formulation F4 was selected as the best formulation due to high dissolution efficiency and rapid drug release, demonstrating the potential of oral medicated jelly as a patient-friendly dosage form.

References

  1. [1]1.Taranum R, Mittapally S. Formulation and Evaluation of Domperidone oral jelly. Int J Pharm Biol. 2018;87(8):25-35.
  2. [2]2.Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1988 ;35(3):244-85.
  3. [3]3.Mutha S, Kshirsagar C, Shelke V, Sawant S. Formulation, development and evaluation of chewable tablet of dicyclomine hydrochloride. Int J Health Sci. 2022;6(S7):1224-36.
  4. [4]4.Ranganathan V, Hui TS, Sri P. Formulation and Evaluation of Buccal Tablets of Diclofenac Sodium using Semi-Synthetic Polymers. Research Journal of Pharmacy and Technology. 2018;11(1):1-8.
  5. [5]5.Singh G, Khinchi MP, Agrawal D, Sharma N, Hussain A. Development, Characterization and Dissolution Study of Solid Dispersion of Diclofenac Sodium by Kneading Technique. Asian Journal of Pharmaceutical Research and Development. 2013 Mar 1:97-102.
  6. [6]6.Kumar S, Chandra D, Singh R, Singh VK, Rai U, Srivastava VP. Bioavailability enhancement of artesunate using solid dispersion techniques. World Journal of Pharmacy and Pharmaceutical Sciences. 2013 Nov 17;3: 1578-95.
  7. [7]7.Kadam VS, Kendre J, Shendarkar GR, Kadam SS. Formulation and Evaluation of Medicated Oral Jelly of Trazodone Hydrochloride. Int. J. Pharm. Sci. Res. 2020; 11(4):62-51.
  8. [8]8.Akshay Javalgikar AJ, Shinde VB. Formulation of Clotrimazole ororetentive jelly. 2016;6(2):21-25.
  9. [9]9.Verma AM, Negi P. Formulation and Evaluation of Oral medicated Jelly of Meclizine HCl. Pharmaspire.2023;15(4):225-9.
  10. [10]10.Natarajan R, Prabhu C, Rajendran NN. Formulation and evaluation of oral jelly containing tadalafil. Int J Res Pharm Chem. 2014;4: 479-483.
  11. [11]11.Cardoz MR, Ravikumar P. Design, development and evaluation of novel oral medicated jellies. Indo American Journal of Pharmaceutical Sciences. 2017 Jun 1; 4(6):1746-1754.
  12. [12]12.Prakash K, Satyanarayana VM, Nagiat HT, Fathi AH, Shanta AK, Prameela AR. Formulation development and evaluation of novel oral jellies of carbamazepine using pectin, guar gum, and gellan gum. Asian J Pharm. 2014 Oct 1;8(4):241-249.
  13. [13]13.Sabri LA, Khasraghi AH, Sulaiman HT. Preparation and evaluation of oral soft chewable jelly containing flurbiprofen. Journal of Advanced Pharmaceutical Technology & Research. 2022 Oct 10;13(4):306-316.
  14. [14]14.Patel JV, Patel VK. Formulation development and evaluation of fast dissolving sublingual film of Dicyclomine HCl. Pharma Science Monitor. 2015 Apr 1;6(2):154-170.
  15. [15]15.Kurawade P, Taware GV. A review on medicated jellies. Int J Pharm Res Appl. 2026;11(1):1043-1054.

Authors (2)

Lavanya B R*1

National College Of Pharmacy

View all publications →

Ashwini Rajendra2

National College Of Pharmacy

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.9 MB
Format: PDF
ViewDownload

Summarise this paper with AI:

GoogleGooglePerplexityPerplexityGrokGrokChatGPTChatGPTClaudeClaude

Article Information

Published in:

October 2026 Issue 5 (Vol. 16, Issue 5, 2026)

AJPTR5160003

AJPTR-02-002502

32-50

2026-10-02

JATS XML

Article Impact

Views:4,024
Downloads:753

How to Cite

R*1, L. B., & Rajendra2, A. (2026). Formulation and Evaluation of Oral Medicated Jelly Containing Diclofenac Sodium and Dicyclomine HCl. American Journal of PharmTech Research, 16(5), 32-50. https://ajptr.com/articles/AJPTR5160003

Article Actions

Whatsapp